Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03042507
Other study ID # 1012011424R005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 20, 2012
Est. completion date February 2013

Study information

Verified date July 2019
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Analysis of data from the recently completed NIH Child Comprehensive Behavioral Intervention for Tics (CBIT) study found a manualized behavioral treatment approach strongly superior to psychoeducation/supportive therapy for reducing tic severity in 9-16 year-old youths with TS or other Chronic Tic Disorders. Buoyed by the success of the NIH study, the research group now seeks to extend and disseminate the CBIT treatment through the systematic adaptation of the CBIT protocol for use across a broader range of ages and treatment settings.

The goal of the this project is to develop a downward extension of the CBIT therapist guide and parent workbook for use in 4-8 year old children with chronic tics. The revised CBIT-JR manual/workbook will be pilot tested in five children at each of the three study sites (UCLA, UWM, Weill Cornell) in order to provide initial data regarding treatment feasibility and acceptability as well as our ability to implement the new intervention, along with relevant quality control procedures, consistently across sites. These pilot data will then be used to seek R01 support for a larger controlled multisite trial examining the efficacy of CBIT-JR.

Although arguably more complex than a single-site design, we have opted for a multsite study in order: 1) to take advantage of the established productive collaborative relationship and collective expertise in childhood tic disorders and psychosocial treatment development across our three sites, 2) to collect the proposed feasibility data in a much shorter period of time than otherwise possible, and as noted above 3) to demonstrate the cross-site portability of the treatment - which will be necessary if we are to obtain subsequent funding for a larger-scale efficacy trial.


Description:

The overall aim of the proposed project is to develop and obtain preliminary feasibility and acceptability data for a family-based behavioral intervention to reduce tic severity and the negative impact of TS-related symptoms in young children (ages 4-8) with chronic tics and Tourette syndrome. This intervention entails the use of targeted psychoeducation about tics and related conditions and a functional analytic protocol designed to identify and correct environmental influences thought to exacerbate and/or maintain child tic expression. Although similar to the family-based component used in our recently completed CBITS trial for older children, an independent body of literature supports the efficacy of functional analysis for ameliorating a variety of both behaviorally and biologically-driven behaviors. The investigators will work with an early child interventionist to adapt the current family-based protocol for younger children. The new manual will then be feasibility tested in anticipation of a larger externally-funded trial to further develop and evaluate the efficacy of this intervention.

More specifically, the study aims are to:

1. Adapt the current CBIT Manual for use with the families of 4-8 year old children with chronic tic disorder. Our revision will be informed by a meeting of the study PI's and Dr. Mary O'Connor, an early childhood interventionist at UCLA to review our current family-intervention and other treatment protocols targeting related psychopathology in young children.

2. Document the feasibility, acceptability, and cross-site portability of the new manual in a small open trial of 15 youngsters (five each at UCLA, UWM, and Weill Cornell).


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date February 2013
Est. primary completion date December 29, 2012
Accepts healthy volunteers No
Gender All
Age group 4 Years to 8 Years
Eligibility Inclusion Criteria:

1. age 4-8

2. presence of motor and/or vocal tics for at least 6 months.

3. tics are of at least moderate clinical severity as evidenced by a Clinical Global Impressions (CGI) Severity score of 4 or higher (tic symptoms clearly noticeable to family and occasionally to families and associated with at least some minimal level of distress and/or interference.

4. free of PDD or other developmental disability

5. IQ estimate of 70 or higher

6. comorbid disorder (e.g., ADHD, OCD, ODD) will be allowed provided that the tic symptoms are of primary concern to parents and comorbid symptoms are not of sufficient severity to require immediate treatment other than that provided by the current study.

7. pre-existing stable medication, tic or otherwise, will also be allowed provided the family agrees to refrain from med changes over the course of the study if at all possible.

8. sufficient command of the English language to comply with study protocol.

Exclusion Criteria:

-

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Comprehensive Behavioral Intervention for Tics (CBIT)
The existing CBIT protocol includes a functional assessment procedure designed to identify relevant contextual variables (both antecedent and consequent) impacting tic expression and guide the development of an individualized behavioral program to neutralize these contextual influences in the service of tic reduction and psychoeducational component. Given the central role that negative social reactions typically play in tic exacerbation and maintenance, psychoeducation about tics is systematically provided to parents, siblings, and other caretakers and prominent individuals in the child's life. The other primary CBIT component, Habit Reversal Training (HRT), is used to weaken or eliminate the negative reinforcement cycle created by tic-contingent reduction in premonitory urge.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Weill Medical College of Cornell University University of California, Los Angeles, University of Wisconsin, Milwaukee

Outcome

Type Measure Description Time frame Safety issue
Primary Yale Global Tic Severity Scale (YGTSS). Change in tic severity from baseline to week 8 as measured by the YGTSS. Baseline, week 8
See also
  Status Clinical Trial Phase
Recruiting NCT00965211 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome N/A
Recruiting NCT00152750 - Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD Phase 4
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Terminated NCT00226824 - Safety Study of Galantamine in Tic Disorders Phase 4
Completed NCT01244633 - Ecopipam Treatment of Tourette Syndrome Phase 1/Phase 2
Recruiting NCT04805385 - Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome N/A
Completed NCT00026000 - Brain Activation in Vocal and Motor Tics N/A
Terminated NCT00001260 - Brain Tissue Collection for Neuropathological Studies
Completed NCT02102698 - Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years Phase 2
Withdrawn NCT02112253 - Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome Phase 1/Phase 2
Withdrawn NCT01133353 - A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome Phase 2
Completed NCT02205918 - Brain-Behavior Interactions in Tic Suppression
Terminated NCT00282139 - Aripiprazole in the Treatment of Tourette's Syndrome N/A
Completed NCT01019343 - Physiological Investigations of Movement Disorders N/A
Completed NCT02619084 - Subthalamic Stimulation in Tourette's Syndrome Phase 2
Completed NCT00368433 - Hypersensitivity in Tourette Syndrome N/A
Withdrawn NCT01475383 - Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome Phase 2
Not yet recruiting NCT06361004 - Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome N/A
Completed NCT00139308 - High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome Phase 1